Analysis of p53 mutants for transcriptional activity
- PMID: 1944276
- PMCID: PMC361778
- DOI: 10.1128/mcb.11.12.6067-6074.1991
Analysis of p53 mutants for transcriptional activity
Abstract
The wild-type p53 protein functions to suppress transformation, but numerous mutant p53 proteins are transformation competent. To examine the role of p53 as a transcription factor, we made fusion proteins containing human or mouse p53 sequences fused to the DNA binding domain of a known transcription factor, GAL4. Human and mouse wild-type p53/GAL4 specifically transactivated expression of a chloramphenicol acetyltransferase reporter in HeLa, CHO, and NIH 3T3 cells. Several mutant p53 proteins, including a mouse p53 mutant which is temperature sensitive for suppression, were also analyzed. A p53/GAL4 fusion protein with this mutation was also transcriptionally active only at the permissive temperature. Another mutant p53/GAL4 fusion protein analyzed mimics the mutation inherited in Li-Fraumeni patients. This fusion protein was as active as wild-type p53/GAL4 in our assay. Two human p53 mutants that arose from alterations of the p53 gene in colorectal carcinomas were 30- to 40-fold less effective at activating transcription than wild-type p53/GAL4 fusion proteins. Thus, functional wild-type p53/GAL4 fusion proteins activate transcription, while several transformation competent mutants do so poorly or not at all. Only one mutant p53/GAL4 fusion protein remained transcriptionally active.
Similar articles
-
Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription.Oncogene. 1993 Jul;8(7):1815-24. Oncogene. 1993. PMID: 8510927
-
p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.EMBO J. 1992 Apr;11(4):1383-90. doi: 10.1002/j.1460-2075.1992.tb05183.x. EMBO J. 1992. PMID: 1314165 Free PMC article.
-
The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.Mol Cell Biol. 1993 Jun;13(6):3291-300. doi: 10.1128/mcb.13.6.3291-3300.1993. Mol Cell Biol. 1993. PMID: 8497252 Free PMC article.
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
-
When mutants gain new powers: news from the mutant p53 field.Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20. Nat Rev Cancer. 2009. PMID: 19693097 Review.
Cited by
-
The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein.EMBO J. 1992 Dec;11(13):5013-20. doi: 10.1002/j.1460-2075.1992.tb05608.x. EMBO J. 1992. PMID: 1464323 Free PMC article.
-
The Transactivation Domains of the p53 Protein.Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):a026047. doi: 10.1101/cshperspect.a026047. Cold Spring Harb Perspect Med. 2017. PMID: 27864306 Free PMC article. Review.
-
Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression.Mol Cell Biol. 1993 Sep;13(9):5186-94. doi: 10.1128/mcb.13.9.5186-5194.1993. Mol Cell Biol. 1993. PMID: 8355677 Free PMC article.
-
p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.Mol Cell Biol. 1999 Feb;19(2):1438-49. doi: 10.1128/MCB.19.2.1438. Mol Cell Biol. 1999. PMID: 9891077 Free PMC article.
-
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.Am J Pathol. 1994 Sep;145(3):702-14. Am J Pathol. 1994. PMID: 8080050 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous